Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 337 followers

Latest posts

Last updated 8 minutes ago

Fierce Biotech Layoff Tracker 2026: Takeda takes away 4.5K roles; Valneva reduces workforce

8 minutes ago

As always, if you know of layoffs occurring at a biotech, please...

Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?

19 minutes ago

With the FDA now rudderless following the revelation that commissioner Marty Makary...

Create Medicines fashions $122M fundraise for in vivo CAR-T dreams

about 2 hours ago

As the wave of in vivo CAR-T hype crests, Create Medicines is...

Biogen advances Alzheimer’s tau program despite midphase miss

about 3 hours ago

A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting candidate missed...

Regenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy

about 4 hours ago

Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint...

Aptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development

about 4 hours ago

Aptose Biosciences has scrapped a deal for a blood cancer drug candidate...

Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities

about 22 hours ago

Global contract research organization Icon has announced the opening of a new...

With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’

1 day ago

Three weeks into taking on the role of Lexicon Pharmaceuticals CEO back...

Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

1 day ago

Humacyte was riding high in December 2024 when it secured an FDA...

Fosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset

1 day ago

Fosun Pharma has paid $60 million for an option on AriBio’s late-phase...

Valneva to lay off up to 15% of workforce in face of ‘adverse trend‘ in travel vaccines

1 day ago

Valneva is planning to shrink its headcount by up to 15% as...

Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit

1 day ago

Medtronic will shutter its Santa Rosa facility that produces coronary stents and...